Mass Spectrometry and Biofuels, Ballroom A
The call for increased biofuel production will surely be closely followed by a need for improved methods of analysis. The six presentations in this Tuesday morning session will examine various roles of mass spectrometry in biofuels analysis and will cover topics such as biodiesel characterization, metaproteomic analysis of termite microbes relevant to biofuel development, and multiple reaction monitoring of biofuels systems metabolic pathways.
The call for increased biofuel production will surely be closely followed by a need for improved methods of analysis. The six presentations in this Tuesday morning session will examine various roles of mass spectrometry in biofuels analysis and will cover topics such as biodiesel characterization, metaproteomic analysis of termite microbes relevant to biofuel development, and multiple reaction monitoring of biofuels systems metabolic pathways.
The first presentation in the session will be delivered by Mary Lipton of Pacific Northwest National Laboratory (Richland, Washington) and is titled “Mass Spectrometry in the World of Bioenergy Research: An Overview.” Lipton’s talk will discuss how biological MS characterization of biofuels will be part of the drive toward a fossil fuel–independent future.
Lipton’s presentation will be followed by G. John Langley’s talk, “Biodiesel: Profiling, Stability and MS Solutions.” Langley, of the University of Southampton (Southampton, UK), will cover the age profiling and analysis of biodiesel as it relates to the quality and oxidation of biodiesel fuel stocks.
Kristin E. Burnum’s (Pacific Northwest National Laboratory) presentation, titled “Metaproteome Analysis of a Termite Hindgut Microbial Community: Relevant to Biofuel Development,” will focus on an early step in biofuel development. She will talk about the complete metaproteomic characterization of a laboratory-kept microbial community relevant to biofuel development.
Helge Egsgaard of the Biosystem Division of Risoe-DTU (Roskilde, Denmark) will discuss novel results for the residual bio-char organics in her presentation “Bio-Char Investigated by Analytical Flash Pyrolysis and GC–MS.” She will discuss the characterization of bio-char based on analytical flash pyrolysis combined with GC-MS.
The next presentation will be given by Richard J. Giannone of the Oak Ridge National Laboratory (Oak Ridge, Tennessee) and will be titled “Identification of the Extracellular Cellulolytic Enzymes in Thermophilic Bacteria That Are Important for Microbial Cellulose Degradation to Bioethanol.” In this presentation, Giannone will talk about the first MS-based characterization of extracellular cellulolytic enzymes secreted by bioenergy-related microbes.
The final presentation in the session will be delivered by Francesco Pingitore of Codexis (Redwood City, California). His presentation, titled “Large Array Scheduled MRM Analysis of Metabolic Pathways Using an Enhanced Scan Rate Hybrid Triple Quadrupole/Linear Ion Trap,” will cover HPLC separation followed by the use of a fast scanning hybrid mass spectrometer to perform a metabolomics study of biofuel systems using multiple reaction monitoring and principal component analysis.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
